Comparison of Markov Model and Discrete-Event Simulation Techniques for HIV

ISSN： 1170-7690

Source： PharmacoEconomics, Vol.27, Iss.2, 2009-01, pp. : 159-165

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cost Effectiveness of Donepezil in the Treatment of Mild to Moderate Alzheimer's Disease: A UK Evaluation Using Discrete-Event Simulation

By Getsios Denis

PharmacoEconomics, Vol. 28, Iss. 5, 2010-05 ,pp. : 411-427

Adis International

Access to resources Recommend Favorite

A Discrete-Event Simulation of Smoking-Cessation Strategies Based on Varenicline Pivotal Trial Data

By Xenakis James G.

PharmacoEconomics, Vol. 29, Iss. 6, 2011-06 ,pp. : 497-510

Adis International

Access to resources Recommend Favorite

Modeling Complex Treatment Strategies: Construction and Validation of a Discrete Event Simulation Model for Glaucoma

By van Gestel Aukje Severens Johan L. Webers Carroll A. B. Beckers Henny J. M. Jansonius Nomdo M. Schouten Jan S. A. G.

Value in Health, Vol. 13, Iss. 4, 2010-06 ,pp. : 358-367

Blackwell Publishing

Access to resources Recommend Favorite

Pharmacoeconomic Analyses Using Discrete Event Simulation

By Caro J. Jaime

PharmacoEconomics, Vol. 23, Iss. 4, 2005-01 ,pp. : 323-332

Adis International

Access to resources Recommend Favorite

Discrete event simulation the way forward for economic evaluations

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 477, 2005-01 ,pp. : 4-4

Adis International

Access to resources Recommend Favorite